Decreased VIP and VPAC(2) receptor expression in the biological clock of the R6/2 Huntington's disease mouse

Summary, in English

Huntington's disease (HD) is a fatal genetic neurodegenerative disorder caused by a CAG triplet repeat expansion in the gene encoding the protein huntingtin. The most studied model of HD, the R6/2 transgenic mouse, replicates many features of the disease. In addition to motor, cognitive, and endocrine dysfunctions, these mice exhibit a progressive disruption of circadian rhythms. This is accompanied by an altered expression of the circadian clock genes in the suprachiasmatic nucleus/nuclei (SCN), the principal circadian pacemaker in the brain. The neuropeptide vasoactive intestinal polypeptide (VIP) and its receptor VPAC(2) are highly expressed in the SCN, and VIPergic signaling plays an essential role in maintenance of ongoing circadian rhythmicity. We found a marked reduction in both VIP mRNA and VPAC2 receptor mRNA, quantified by RT-PCR, as well as a decrease in VIP immunostaining in the SCN of R6/2 mice. These changes were coupled to a disruption of circadian rhythm. We observed no loss of neurons in the SCN and therefore suggest that the changes in VIP and VPAC2 receptor are due to their decreased expression. In conclusion, we propose that impaired VIPergic signaling is an additional candidate mechanism for disruption of circadian rhythms in R6/2 mice.

• Författare: Jan Fahrenkrug; Natalija Popovic; Birgitte Georg; Patrik Brundin; Lens Hannibal
• Avdelning/ar: Institutionen för experimentell medicinsk vetenskap
• Publiceringsår: 2007
• Språk: Engelska
• Sidor: 139-148
• Publikation/Tidskrift/Serie: Journal of Molecular Neuroscience
• Volym: 31
• Issue: 2
• Länkar: http://dx.doi.org/10.1385/JMN/31:02:139
• Dokumenttyp: Artikel i tidskrift
• Förlag: Humana Press
• Ämne: Neurosciences
• Nyckelord: suprachiasmatic nucleus; circadian rhythm; Huntington's disease; vasoactive intestinal polypeptide
• Status: Published
• ISBN/ISSN/Övrigt: ISSN: 0895-8696